The uptake of iron and transferrin by the human malignant melanoma cell
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The role of the transferrin homologue, melanotransferrin (p97), in iron metabolism has been studied using the human melanoma cell line, SK-MEL-28, which expresses this antigen in high concentrations. The mechanisms of iron and transferrin uptake were investigated using human transferrin labelled with iodine-125 and iron-59. Internalised and membrane-bound iron and transferrin were separated using the proteinase, pronase. The uptake of iron from transferrin occurred by at least two processes. The first process was saturable and consistent with receptor-mediated endocytosis, involving internalisation of transferrin bound to specific binding sites. Uptake of iron also occurred by a second process which was non-saturable up to 0.06 mg/ml (0.75 microM) and was of higher efficiency than the saturable process. This process of iron uptake may be the dominant one at physiological serum transferrin concentrations. A membrane-bound, pronase-sensitive, temperature-dependent, iron-binding component was also identified. The number of binding sites was estimated to be approx. 340,000 per cell (assuming 2 atoms of iron per site) and it is suggested that this binding component may be melanotransferrin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, cancer cells have increased expression of transferrin receptor-1 and a higher rate of iron uptake from transferrin [55, 56], as well as decreased expression of iron exporters [57].”
From The utility of iron chelators in the management of inflammatory disorders (2015) · cites this paper as [56]
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
Birth Defects Original Article Series: Wilson's Disease
ENGEL, A. G. (1970) · Neurology · doi:10.1212/wnl.20.5.523-a · Cited by 893
Iron withholding: a defense against infection and neoplasia
Weinberg, E. D. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.65 · Cited by 881
Karin, M., & Mintz, B. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69597-9 · Cited by 488
Non-Inverted Versus Inverted Plots in Enzyme Kinetics
Hofstee, B. H. J. (1959) · Nature · doi:10.1038/1841296b0 · Cited by 462
Ciechanover, A., Schwartz, A. L., Dautry-Varsat, A., & Lodish, H. F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44551-0 · Cited by 434
Body Iron Stores and the Risk of Cancer
Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 430
Modulation of cell surface iron transferrin receptors by cellular density and state of activation
Larrick, J. W., & Cresswell, P. (1979) · Journal of Supramolecular Structure · doi:10.1002/jss.400110415 · Cited by 357
Transferrin, biochemistry, physiology and clinical significance
Morgan, E. H. (1981) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(81)90003-0 · Cited by 304
Research works printed but not linked: 11
- Sutherland, 1981, 78, 4515
- Okada, 1985, Cancer Res., 45, 2793
- Baker, 1988, Birth Defects: Original Article Series, Vol. 23, 89
- Seligman, 1986, Am. J. Hum. Genet., 38, 540
- Rose, 1986, 83, 1261
- Hanks, 1949, 71, 196
- Giovanella, 1972, J. Natl. Cancer Inst., 48, 1531
- Visfeldt, 1972, Acta Path. Microbiol. Scand. Section A, 80, 169
- Klausner, 1983, 80, 2263
- Page, 1984, Am. J. Physiol., 246, G26
- Morgan, 1986, 45, 2810
Cited by
The roles of iron in health and disease
Lieu, P. T., Heiskala, M., Peterson, P. A., & Yang, Y. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 804
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Self-citationThe Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
Self-citationThe molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
Self-citationThe role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Metadata
- Authors
- Richardson, D. R., & Baker, E.
- Affiliations
- The University of Western Australia (AU)
- Corresponding author
- Baker, E.
- ORCID
- Richardson, D.R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 1990-06
- Volume
- 1053
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2159401034
- Cited by
- 179
- References
- 51
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 5 · 2017: 1 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 7 · 2012: 6
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Micronutrient Interactions and Effects
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- melanotransferrin, transferrin uptake, iron absorption, melanoma, receptor-mediated endocytosis, iron metabolism, melanoma cell lines
- MeSH terms
- Antigens, Neoplasm, Binding Sites, Cell Membrane, Deferoxamine, Endocytosis, Humans, Iodine Radioisotopes, Iron, Iron Radioisotopes, Kinetics, Melanoma, Neoplasm Proteins, Pronase, Receptors, Transferrin, Temperature, Transferrin, Tumor Cells, Cultured, Melanoma-Specific Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The uptake of iron and transferrin by the human malignant melanoma cell. https://app.cochat.ai/papers/10.1016/0167-4889(90)90018-9
- The paper
- Richardson, D. R., & Baker, E. (1990). The uptake of iron and transferrin by the human malignant melanoma cell. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/0167-4889(90)90018-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.